Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany; Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
Universitätsklinik für Kardiologie, Herzzentrum Leipzig, Leipzig, Germany.
Cardiovasc Revasc Med. 2023 Apr;49:22-27. doi: 10.1016/j.carrev.2022.12.008. Epub 2022 Dec 30.
The percutaneous treatment of severely calcified coronary lesions has been associated with lower performance of coronary stents and poor clinical long-term outcomes. Adequate lesion preparation before stent implantation is of paramount importance to minimize the risk of stent failure. Balloon-based techniques for lesion preparation have been the subject of numerous investigations, albeit comparative data from randomized trials are scarce.
The ISAR-CALC 2 (ClinicalTrials.gov: NCT05072730) is an investigator-initiated, prospective, randomized, multicentre, assessors-blind, open-label trial designed to compare a lesion preparation strategy with either super high-pressure balloon or intravascular lithotripsy (IVL) before drug-eluting stent (DES) implantation in patients with severely calcified, undilatable coronary lesions. In total, 80 patients are required for trial completion. The primary endpoint will be final angiographic minimal lumen diameter (MLD) after stent implantation. Key secondary endpoints include stent expansion assessed by optical coherence tomography (OCT), procedural and strategy success, need for complementary lesion preparation with rotational atherectomy, acute lumen gain, and major adverse cardiac events up to 30-day follow-up.
The ISAR-CALC 2 trial aims to demonstrate the superiority of a lesion preparation strategy with a super high-pressure balloon as compared with intravascular lithotripsy prior to DES implantation in patients with severely calcified undilatable coronary lesions.
经皮严重钙化冠状动脉病变的治疗与冠状动脉支架性能降低和临床长期预后不良有关。支架植入前充分的病变准备对于最大限度地降低支架失败的风险至关重要。基于球囊的病变准备技术已经进行了大量的研究,尽管随机试验的比较数据很少。
ISAR-CALC 2(ClinicalTrials.gov:NCT05072730)是一项由研究者发起的、前瞻性的、随机的、多中心的、评估者盲法的、开放性标签试验,旨在比较在严重钙化、不可扩张的冠状动脉病变患者中,在药物洗脱支架(DES)植入前使用超高压力球囊或血管内碎石术(IVL)进行病变准备的策略。试验完成共需 80 例患者。主要终点将是支架植入后的最终血管造影最小管腔直径(MLD)。关键次要终点包括光学相干断层扫描(OCT)评估的支架扩张、手术和策略成功率、需要补充旋磨术进行病变准备、急性管腔获得和 30 天随访时的主要不良心脏事件。
ISAR-CALC 2 试验旨在证明在严重钙化不可扩张的冠状动脉病变患者中,与血管内碎石术相比,在 DES 植入前使用超高压力球囊进行病变准备策略的优越性。